Biotechnology

MOMA Therapeutics is primarily engaged in the field of biotechnology, focusing on the discovery of precision medicines by targeting molecular machines that underlie human disease. The company utilizes a biomechanics engine that integrates various scientific disciplines such as biochemistry, biophysics, structural biology, computation, chemistry, and functional genomics, which are all core aspects of biotechnology.

Canopy Biosciences is primarily engaged in the field of biotechnology, offering a range of biotechnology-related products and services including spatial biology instruments, high-plex biomarker imaging, single-cell RNA-Seq services, CLIA-certified laboratory services, and various consumables and reagents.

Emulate is primarily engaged in the field of biotechnology, as evidenced by their development and provision of Organ-Chip models and the Human Emulation System, which are used to emulate human biology and study drug efficacy and mechanisms.

Sixfold Bioscience is primarily engaged in the field of biotechnology, specifically focusing on the commercialization of patented drug delivery systems for RNA therapeutics. Their work involves innovative approaches to RNA delivery, combining machine learning, high-throughput generation, and testing of RNA variants, which are core activities in the biotechnology sector.

Eleven Therapeutics is primarily engaged in the development of RNA therapeutics, which falls under the field of biotechnology.

Adicet Bio is primarily engaged in the field of biotechnology, specifically in developing allogeneic off-the-shelf genetically modified gamma delta T cells for autoimmune diseases and cancer, which involves advanced biotechnological processes and innovations.

Seed Health is primarily engaged in the field of biotechnology as it utilizes advanced computational biology, microbial genomics, and ultra-deep sequencing to advance microbiome science, and conducts research programs to optimize the development and maturation of the human microbiome.

Notch Therapeutics is primarily engaged in the field of biotechnology, as evidenced by their focus on developing cellular immunotherapies from pluripotent stem cells, their proprietary T cell-production platform, and their collaborations with other biotech companies and research institutions.

Celling Biosciences is primarily engaged in the field of biotechnology, focusing on the science, research, and development of autologous cellular therapy and other biotechnological applications.